. In addition, a potential role for its use in chemotherapy is being considered because of the ability of this drug to be preferentially cytotoxic towards hypoxic cells (Hall & Roizin-Towle, 1975; Moore et al., 1976; Sridhar et al., 1976; Stratford & Adams, 1977 foetal calf serum (FCS, Gibco-Biocult Ltd.). Cells were kept in log phase at concentrations ranging between 105 and 106/ml. Cytotoxicity experiments.-250ml spinner flasks were fitted with a gas inlet/outlet system and a sidearm through which samples could be withdrawn. Asynchronous, logphase cells at a concentration of 2 x 105/ml were suspended in MEM + 7.5 % FCS and held in a water bath at 37TC. The compounds were dissolved in MEM+7.5% FCS and added to the suspension which was buffered with bicarbonate to pH 7-4. When appropriate, the spinner containing cells was deaerated by flowing N2 plus 5% CO2 (<10 pts/106 02; BOC Ltd) at 500 ml/min over the surface of the stirred suspension throughout the experiment. Samples of cells were withdrawn at appropriate times, centrifuged, resuspended, counted, diluted, plated in MEM+ 15% FCS and incubated for 7
alone, and it is suggested that these compounds sensitize by independent mechanisms.
For cells held at 37°C, cis-Pt(II) shows much greater toxicity to hypoxic cells than to aerobic cells. In combination with misonidazole, no additional cytotoxic effect is shown towards aerobic cells than that seen for cis-Pt(II) alone. However, there is additional killing of hypoxic cells when they are treated with both drugs.
THE USE of misonidazole (MISO) as a radiosensitizer of hypoxic cells in tumours is well established (for review see . In addition, a potential role for its use in chemotherapy is being considered because of the ability of this drug to be preferentially cytotoxic towards hypoxic cells (Hall & Roizin-Towle, 1975; Moore et al., 1976; Sridhar et al., 1976; Stratford & Adams, 1977) . If MISO is to be of value in chemotherapy it is necessary to use it in combination with drug(s) which can sterilize the aerobic fraction of tumour cells. We are currently studying the cytotoxic effect of some common antineoplastic drugs, including a cis-Platinum complex, cis-dichlorodiammineplatinum-(II) (cis-Pt(II)). cis-Pt(II) is a proven cytotoxic agent (see Roberts & Thomson, 1979 , for review) and can also act as a radiosensitizer of hypoxic cells (Richmond & Powers, 1976; Richmond et al., 1977; Douple & Richmond, 1978; Nias et al., 1979 Cytotoxicity experiments.-250ml spinner flasks were fitted with a gas inlet/outlet system and a sidearm through which samples could be withdrawn. Asynchronous, logphase cells at a concentration of 2 x 105/ml were suspended in MEM + 7.5 % FCS and held in a water bath at 37TC. The compounds were dissolved in MEM+7.5% FCS and added to the suspension which was buffered with bicarbonate to pH 7-4. When appropriate, the spinner containing cells was deaerated by flowing N2 plus 5% CO2 (<10 pts/106 02; BOC Ltd) at 500 ml/min over the surface of the stirred suspension throughout the experiment. Samples of cells were withdrawn at appropriate times, centrifuged, resuspended, counted, diluted, plated in MEM+ 15% FCS and incubated for 7-10 days at 37°C before scoring for colony formation. Further details * To whom correspondence should be addressed. of the technique are described elsewhere (Stratford & Adams, 1977) .
Radiation experiments.-Cells were harvested from log-phase cultures, diluted appropriately and added to glass Petri dishes containing 2-5 ml MEM, supplemented -v%ith 15% FCS. Cells were allowed to attach at 37°C for 2-3 h before the medium was removed and replaced with fresh medium containing drug(s). Irradiations with 60Co y-rays were carried out in "dural" containers which can hold 4 Petri dishes (Cooke et al., 1976) . These vessels were made hypoxic by purging with N2+5% CO2 (BOC Ltd) for 1 h, after which the vessels were sealed and irradiated at room temperature at a dose rate of 4-2 gray/min. After irradiation, the medium was removed and replaced with fresh MEM + 15% FCS and the cells incubated for 7-9 days before scoring for colony formation.
Compounds.-Misonidazole was supplied by Dr C. Smithen of Roche Products Ltd, Welwyn Garden City, Herts, and cis-Pt(II) by Dr K. Harrap, Institute of Cancer Research, Sutton, England.
RESULTS

Cytotoxicity 8tudies
The effect of 5mM MISO (1 mg/ml) on Chinese hamster V79-379A cells held under aerobic or hypoxic conditions is shown in Fig. 1 (Fig. 2) . The dotted line is the response for hypoxic cells treated with 5mm MISO (Fig. 1) Assuming an unchanged extrapolation number, enhancement ratios for other concentrations were calculated from a single survival point (usually between 2 x 10-2 and 10-1) which was obtained by appropriate choice of radiation dose.
Enhancement ratios (ER) obtained for hypoxic cells irradiated in the presence of MISO alone were similar to those reported previously for this cell line (Adams et al., 1976) and this dependence of ER on MISO concentration is shown by the dashed line in Fig. 5 . The maximum concentration of cis-Pt(II) tested was 5 pM, and this gave routinely an ER of 1 12 (see Fig. 4 ). For combination studies, the radiation response of hypoxic cells was plus MISO are greater than those for MISO alone. In addition, the response curves (Fig. 5) appear parallel, which suggests that the two compounds show a degree of additivity that cannot be explained if they sensitize wholly by the same mechanism(s). DISCUSSION cis-Platinum complexes can increase the radiation sensitivity of cells in vitro under both aerobic and hypoxic conditions (Richmond & Powers, 1976; Szumiel & Nias, 1976; Nias & Szumiel, 1977; Richmond et al., 1977; Douple & Richmond, 1978) with the greatest effect apparently on the hypoxic cells (Richmond & Powers, 1976; Richmond et al., 1977; Douple & Richmond, 1978; Nias et al., 1979) . In the present work 5tM cis-Pt(II) increases the radiation sensitivity of hypoxic mammalian cells, giving an ER of 1-12. The combination of cis-Pt(II) and MISO gives at least an additive response for radiation sensitization of hypoxic cells. This can be rationalized if we consider that the ER of 5/LM cis-Pt(II) (1.12) is equivalent to 20Mm MISO. On the basis of simple equivalence, if the two compounds are acting similarly, the combination of 5tM cis-Pt(II) and 20Mm MISO should give an ER similar to that seen for 40pM MISO, viz. 1X20 . In fact the observed ER is about 1-40, a value that could only be expected if the compounds are operating on different lesions and/or by different mechanism(s). If this effect were to hold for other cis-Platinum complexes, and if such complexes in combination with MISO produced no increased toxicity in man, this type of drug combination could substantially increase ERs obtainable in radiotherapy.
We have demonstrated that, as a cytotoxic agent, cis-Pt(II) is considerably more toxic to hypoxic cells than to aerobic cells. The difference in toxicity is seen after only 2h exposure to the drug, which is likely to preclude the effect being due to any cell-cycle redistribution induced by hypoxia (Roberts & Fraval, 1978) . It is possible that the anaerobic environment allows biochemical reduction of cis-Pt(II) to a platinum (I) intermediate. This is a highly reactive species (Richmond & Simic, 1978) which could interact with vital cellular macromolecules. Alternatively, hypoxia may inhibit repair of DNA damage caused by cisPt(II), and this may also modify radiation sensitivity.
The differential cytotoxicity of cisPt(II) may be important in influencing the efficacy of the cis-platinum complexes used clinically, since there is evidence that hypoxic cells may be resistant to some chemotherapeutic drugs. There are two possible reasons for this hypoxic resist-ance. Firstly, hypoxic cells tend to be located near necrotic or poorly vascularized regions in tumours, and therefore these cells are probably less accessible to some chemotherapeutic agents. Secondly, clonogenic cells temporarily rendered hypoxic may become non-cycling, or have their progression through the cell cycle slowed down.
Previous work has shown that bleomycin, actinomycin D and adriamycin are less effective in killing hypoxic than aerobic cells (Roizin-Towle & Hall, 1978; Adams et al., 1979; Sutherland et al., 1979; Smith et al., unpublished data) . It has been suggested that drugs that are specifically toxic to hypoxic cells may be useful in improving combination chemotherapy. Some nitro-aromatic and nitro-heterocyclic compounds show this property and one of them, MISO, has suitable pharmacological characteristics of bioavailability and tumour penetration (Dische et al., 1977; Ash et al., 1979) .
The combination of MISO and cis-Pt(II) kills hypoxic cells much more effectively than either drug alone. Therefore, if potentially clongenic hypoxic cells are important in tumour response to chemotherapy, a combination of MISO and cisPt(II) may be useful, particularly since the in vitro data reported here show no additional killing of aerobic cells.
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